Chemotherapy At Home Services Market To Reach $2.63 Billion By 2030

Chemotherapy At Home Services Market Growth & Trends

The global chemotherapy at home services market size is expected to reach USD 2.63 billion by 2030, based on a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.28% during the forecast period. The market's growth can be attributed to the increasing shift of patients from hospital to home care settings. Moreover, the lower cost of services compared to hospital settings is expected to boost the demand for the market.

Cancer patients have rapidly adopted technologically advanced or improved chemotherapy devices and telemedicine to benefit from treatment at remote locations with patient safety and convenience. This is expected to boost the growth of the market over the forecast period. Many portable devices have been launched recently to improve the administration of chemotherapy drugs, contributing to the market’s growth. For instance, in March 2022, Shanghai MicroPort Lifesciences Co., Ltd. received marketing approval for “AutoEx Chemotherapy Infusion Pump” from the National Medical Products Administration (NMPA) of China.

The COVID-19 pandemic positively impacted the market owing to increased demand and physicians' promotion of chemotherapy at home services. Moreover, due to the shortage of beds in the hospital settings, companies were focusing on transitioning patients from the hospital to in-home, creating demand for the services. Hence, many service providers launched services to cater to the growing demand for chemotherapy post-pandemic. For instance, in September 2022, Jivika Healthcare launched the ChemoAtHome service in Mumbai to provide access to affordable and high-quality cancer care services to patients.

 Request a free sample copy or view report summary: Chemotherapy At Home Services Market Report

Chemotherapy At Home Services Report Highlights

• Based on the product, the oral segment held the largest market share in 2022 owing to the lower cost of the products and the availability of reimbursement for such products in the market

• Based on the cancer type, leukemia dominated the market in 2022, as chemotherapy is considered one of the primary treatment methods for leukemia patients. The high share of the segment can be due to the high preference for home-based chemotherapy by leukemia patients

• Based on the region, the North America region held the largest market share in 2022 owing to the growing incidence of cancer in the region, and the rising number of providers offering chemotherapy at home services

• The market is highly fragmented, with the presence of small-scale businesses offering home-based chemotherapy services. Many companies in developing countries are partnering with cancer treatment centers to offer at home cancer treatment services

Chemotherapy At Home Services Market Segmentation

Grand View Research has segmented the global chemotherapy at global home services market based on product, cancer type, and region:

Chemotherapy At Home Services Product Outlook (Revenue, USD Million, 2018 - 2030)

• Oral

• Infusion

Chemotherapy At Home Services Cancer Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Breast Cancer

• Colon Cancer

• Rectum Cancer

• Cervix Uteri Cancer

• Lung Cancer

• Prostate Cancer

• Ovarian Cancer

• Leukemia

Chemotherapy At Home Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Norway

  • Denmark

  • Sweden

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Mexico

  • Brazil

  • Argentina

• Middle East & Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Chemotherapy At Home Services Market

• Sciensus Pharma Services Limited

• Portea Medical

• Ubiqare

• Penn Medicine (The Trustees of the University of Pennsylvania)

• Advocate Health Care

• View Health Pty Ltd group (chemo@home Pty Ltd)

• Vitalis Health and Home Care Pty Ltd

• Medibank Private Limited

• TCP Homecare

• LloydsPharmacy Clinical Homecare